Exeter Financial, LLC Amgen Inc Transaction History

Exeter Financial, LLC

$222 Million
Q3 2024

A detailed history of Exeter Financial, LLC transactions in Amgen Inc stock. As of the latest transaction made, Exeter Financial, LLC holds 11,111 shares of AMGN stock, worth $3.27 Million. This represents 1.61% of its overall portfolio holdings.

Number of Shares

11,111

Previous 11,473 3.16%

Holding current value

$3.27 Million

Previous $3.58 Million 0.11%

% of portfolio

1.61%

Previous 1.74%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 07, 2024	SELL	$309.38 - $337.38 $111,995 - $122,131	-362 Reduced 3.16%	11,111 $3.58 Million
Q2 2024 Jul 12, 2024	SELL	$262.75 - $319.31 $159,226 - $193,501	-606 Reduced 5.02%	11,473 $3.58 Million
Q1 2024 Apr 15, 2024	BUY	$268.87 - $324.56 $22,853 - $27,587	85 Added 0.71%	12,079 $3.43 Million
Q4 2023 Jan 16, 2024	BUY	$255.7 - $288.46 $83,613 - $94,326	327 Added 2.8%	11,994 $3.45 Million
Q3 2023 Oct 16, 2023	BUY	$218.65 - $271.46 $68,656 - $85,238	314 Added 2.77%	11,667 $3.14 Million
Q2 2023 Jul 27, 2023	BUY	$214.27 - $253.37 $318,405 - $376,507	1,486 Added 15.06%	11,353 $2.52 Million
Q1 2023 May 10, 2023	BUY	$225.79 - $275.2 $11,741 - $14,310	52 Added 0.53%	9,867 $2.39 Million
Q4 2022 Jan 24, 2023	SELL	$229.03 - $291.01 $10,764 - $13,677	-47 Reduced 0.48%	9,815 $0
Q3 2022 Oct 13, 2022	BUY	$224.46 - $253.15 $82,152 - $92,652	366 Added 3.85%	9,862 $2.22 Million
Q2 2022 Jul 20, 2022	BUY	$230.71 - $256.74 $62,753 - $69,833	272 Added 2.95%	9,496 $2.31 Million
Q1 2022 Apr 27, 2022	BUY	$219.27 - $242.57 $184,406 - $204,001	841 Added 10.03%	9,224 $2.23 Million
Q4 2021 Jan 25, 2022	BUY	$198.88 - $227.6 $520,270 - $595,401	2,616 Added 45.36%	8,383 $1.93 Million
Q3 2021 Oct 22, 2021	BUY	$212.27 - $248.7 $53,279 - $62,423	251 Added 4.55%	5,767 $1.23 Million
Q2 2021 Jul 30, 2021	BUY	$233.58 - $259.14 $233 - $259	1 Added 0.02%	5,516 $1.37 Million
Q1 2021 Apr 30, 2021	BUY	$221.91 - $258.6 $27,960 - $32,583	126 Added 2.34%	5,515 $1.37 Million
Q2 2020 Jul 21, 2020	SELL	$197.81 - $242.74 $84,069 - $103,164	-425 Reduced 7.31%	5,389 $1.27 Million
Q1 2020 Apr 23, 2020	BUY	$182.24 - $241.7 $191,352 - $253,785	1,050 Added 22.04%	5,814 $1.18 Million
Q4 2019 Jan 29, 2020	SELL	$189.21 - $243.2 $47,302 - $60,800	-250 Reduced 4.99%	4,764 $1.15 Million
Q2 2019 Jul 26, 2019	BUY	$166.7 - $195.41 $20,837 - $24,426	125 Added 2.56%	5,014 $924,000
Q1 2019 Apr 09, 2019	SELL	$180.87 - $203.88 $43,408 - $48,931	-240 Reduced 4.68%	4,889 $929,000
Q2 2018 Sep 24, 2018	BUY	$166.05 - $186.51 $1,660 - $1,865	10 Added 0.2%	5,129 $947,000
Q1 2018 Sep 24, 2018	BUY	$169.43 - $198.0 $4,235 - $4,950	25 Added 0.49%	5,119 $873,000
Q4 2017 Sep 24, 2018	BUY	$168.79 - $188.59 $859,816 - $960,677	5,094	5,094 $886,000

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Exeter Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Exeter Financial, LLC with notifications on news.

Account

Exeter Financial, LLC Amgen Inc Transaction History